Accenture Life Sciences Blog
Pharmaceutical and medical technology companies face both complexity and opportunity when navigating the current healthcare landscape. Accenture experts will share their insights and opinions on how pharmaceutical and medical technology companies can rethink, reshape and restructure for better patient outcomes during complex times.
 
 
10,000 patients across the globe reveal their unmet service needs during the patient journey Accenture commissioned a survey of 10,000 patients from the US, UK, France, Germany and Brazil on the role and use of patient services in enhancing the ...
 
 
 
 
The rapid improvements in growth forecasts for the High Performers reflects their ongoing commitment to a strategic focus on bringing innovative new science to market in key growth therapeutic areas. However, it also reflects their ability to ...
 
 
 
 
Highlights from the Healthcare Businesswoman’s Association Women of the Year event and opportunities and challenges in today's digital workplace. I am very fortunate to work alongside bright, passionate people who have a unique way of doing thing...
 
 
 
 
Operating margins are under pressure, and the growth promised from biopharma innovation is entering an increasingly tough payer reimbursement climate. As the big pharma peer group revenue growth slowed in the late 2000s, companies were able to m...
 
 
 
 
Pharmaceutical industry growth is forecast to return in 2016, with the High Performers expecting to see significantly higher growth than their peers. The peer group studied in our research saw steadily slowing growth in the 2000’s, before a perio...
 
 
 
 
The life sciences industry isn’t typically known for being first movers when it comes to the latest technology—but the cloud is changing all that. Pharmaceutical companies have led the way with the adoption of cloud-based CRM systems to empower th...
 
 
 
 
A new wave of science driven innovation is capturing the imaginations of investors. Confidence is back and expectations are high with companies making strategic moves. Pharma company valuations have on average out-performed the main equity mark...
 
 
 
 
From Accenture Strategy for Life Sciences M&A activity remains at an all-time high as pharma, biotech and medical device companies optimize their product portfolios and reinvigorate R&D pipelines. Last year marked a high point for merger...
 
 
 
 
Pharma companies are leveraging technology and mobile apps to develop patient-centric solutions to address specific, previously unmet, needs. I had the pleasure of serving as host at the recent eyeforpharma Philadelphia Awards during the eyeforph...
 
 
 
 
Medical technology CEOs believe government healthcare incentives are misaligned with industry trends toward shorter and less frequent hospital stays. At the end of March, I had the pleasure of joining leaders of healthcare and medical device comp...
 
 
 Next >>
About the Authors
Anne O'Riordan
Anne O'Riordan is a Senior Managing Director responsible for Accenture's Global Life Sciences Practice. Worked throughout Europe, th...
 
Andrea Brueckner
Andrea Brueckner is a Managing Director in Accenture’s Life Sciences practice. She also leads the practice in Europe, Africa and Lat...
 
Doug Mowen
Doug Mowen is a Managing Director for Accenture’s Medical Technology Practice. With 25 years of experience and 15 years serving the ...
 
James_Crowley
James Crowley is a Managing Director and Life Sciences Lead within Accenture Strategy. In his current role he focuses on helping C-s...
 
Jeff Elton
Jeff Elton is a Managing Director of Accenture Life Sciences, with broad responsibilities for the strategy and partnerships f...
 
Kevin Julian
Kevin Julian is a Managing Director and Global Lead for Accenture's Life Sciences Accelerated R&D Services. Previously he was re...
 
Shawn Roman
Shawn Roman is a Managing Director in Accenture Life Sciences and leads the North America Commercial Services practice. Mr. Roman ha...
 
Tom Schwenger
Tom Schwenger is a Senior Managing Director and the Life Sciences North America Client Service Group Lead. In this role, Tom is resp...
 
 

 

By using this site you agree that we can place cookies on your device. See our privacy statement for details.